BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 72 filers reported holding BEAM THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $35,346,886 | -25.5% | 1,469,725 | -1.0% | 1.68% | -7.6% |
Q2 2023 | $47,422,404 | -3.9% | 1,485,199 | -7.9% | 1.82% | -15.0% |
Q1 2023 | $49,362,318 | -28.7% | 1,612,094 | -9.0% | 2.14% | -24.4% |
Q4 2022 | $69,247,658 | -18.0% | 1,770,587 | -0.1% | 2.83% | -13.5% |
Q3 2022 | $84,465,000 | +18.0% | 1,772,987 | -4.2% | 3.28% | +19.8% |
Q2 2022 | $71,609,000 | -31.9% | 1,849,887 | +0.8% | 2.73% | -16.7% |
Q1 2022 | $105,206,000 | -30.0% | 1,836,050 | -2.6% | 3.28% | -3.9% |
Q4 2021 | $150,283,000 | -12.5% | 1,885,850 | -4.5% | 3.42% | +14.0% |
Q3 2021 | $171,845,000 | -35.0% | 1,975,006 | -3.8% | 3.00% | -23.3% |
Q2 2021 | $264,178,000 | +30.3% | 2,052,506 | -19.0% | 3.91% | +36.9% |
Q1 2021 | $202,703,000 | -34.3% | 2,532,523 | -33.0% | 2.86% | -23.6% |
Q4 2020 | $308,457,000 | +276.5% | 3,778,262 | +13.6% | 3.74% | +148.3% |
Q3 2020 | $81,917,000 | -12.8% | 3,327,262 | -0.9% | 1.50% | -13.3% |
Q2 2020 | $93,995,000 | +55.4% | 3,356,958 | -0.1% | 1.74% | +2.4% |
Q1 2020 | $60,467,000 | – | 3,359,258 | – | 1.70% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MWG Management Ltd. | 2,362,635 | $205,573,000 | 24.93% |
HSG Holding Ltd | 796,089 | $69,268,000 | 6.22% |
DC Investments Management, LLC | 21,010 | $1,828,000 | 3.41% |
Redmile Group, LLC | 1,975,006 | $171,845,000 | 3.00% |
Casdin Capital, LLC | 818,820 | $71,246,000 | 1.77% |
Evolutionary Tree Capital Management, LLC | 44,390 | $3,862,000 | 1.71% |
HHLR ADVISORS, LTD. | 1,448,161 | $126,004,000 | 1.65% |
Nan Fung Group Holdings Ltd | 54,903 | $4,777,000 | 1.53% |
ARK Investment Management | 6,841,722 | $595,298,000 | 1.43% |
BRANDYWINE MANAGERS, LLC | 12,900 | $1,122,000 | 1.17% |